Published in:
01-07-2020 | Addiction | Concise Research Report
Increased Awareness Needed for Inpatient Substance Use Disorder Treatment in Drug Use–Associated Infective Endocarditis
Authors:
Alexandra E. Mihm, PharmD, Mary C. Cash, PharmD Candidate, Sarah A. Nisly, PharmD, Kyle A. Davis, PharmD
Published in:
Journal of General Internal Medicine
|
Issue 7/2020
Login to get access
Excerpt
The incidence of drug use–associated infective endocarditis (DUA-IE) has increased in the USA, with North Carolina witnessing an extreme 12-fold increase in cases over the past decade.
1 While patients are at increased risk of morbidity and mortality, inpatient IE management primarily focuses on treating the acute infection, leaving the underlying substance use disorder unaddressed.
1, 2 Utilization of substance abuse resources, including medication-assisted treatment (MAT), during inpatient treatment may prevent further abuse; minimize recurrent infections, readmissions, and mortality; and reduce healthcare costs.
2, 3 Much remains unknown surrounding patient characteristics and resources offered during hospitalization for DUA-IE and the impact of resources on patient outcomes. The objective of this study was to describe and evaluate substance abuse resources offered during inpatient DUA-IE treatment. …